Matches in Wikidata for { <http://www.wikidata.org/entity/Q63571201> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q63571201 description "clinical trial" @default.
- Q63571201 description "ensayu clínicu" @default.
- Q63571201 description "klinisch onderzoek" @default.
- Q63571201 description "клінічне випробування" @default.
- Q63571201 name "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))" @default.
- Q63571201 type Item @default.
- Q63571201 label "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))" @default.
- Q63571201 prefLabel "Effects of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition on Arterial Wall Inflammation in Patients With Elevated Lipoprotein(a) (Lp(a))" @default.
- Q63571201 P1050 Q63571201-531C31DB-A751-4FF3-9509-156505233E06 @default.
- Q63571201 P1132 Q63571201-FEE1E31B-82F9-4F22-B8AC-C44DDBE15494 @default.
- Q63571201 P1476 Q63571201-B46577D4-BBA7-4007-A594-AFE2B924979D @default.
- Q63571201 P17 Q63571201-50B563F6-8DF7-4F66-AC84-EFEA5E06BCFB @default.
- Q63571201 P17 Q63571201-58A31E44-5AF3-4B75-8437-A042C9251844 @default.
- Q63571201 P17 Q63571201-8E45633E-5D97-44DD-ADD4-BA99084FD59E @default.
- Q63571201 P1813 Q63571201-CED01E88-2326-4265-9D0D-BF9F2487DF17 @default.
- Q63571201 P2899 Q63571201-45BBFC4C-FDB0-4EC9-8982-893A3F31BD74 @default.
- Q63571201 P3098 Q63571201-9477B7F0-5E43-45F6-AC7C-2353DEE55E11 @default.
- Q63571201 P31 Q63571201-DB731E64-258D-4CA2-8D0A-5C5395F72B25 @default.
- Q63571201 P4135 Q63571201-0D92179F-0567-4931-B947-A530BA4CE7F6 @default.
- Q63571201 P4844 Q63571201-0A30D638-C01A-4433-B8C0-0213043C72EB @default.
- Q63571201 P580 Q63571201-D3858629-4F12-4784-ACDD-82354980B958 @default.
- Q63571201 P582 Q63571201-568BAA8A-FD2B-48DD-9AD3-937BFFBD4C29 @default.
- Q63571201 P6099 Q63571201-90C428E0-32FD-42C8-8671-B14226B8BCD8 @default.
- Q63571201 P8363 Q63571201-3B274513-8EB0-4F16-AD8A-820CBB929C41 @default.
- Q63571201 P859 Q63571201-A9888675-1AD4-4AFC-BCED-8CF7EACBFB43 @default.
- Q63571201 P1050 Q101991 @default.
- Q63571201 P1132 "+129" @default.
- Q63571201 P1476 "A RaNdomized Double-blInd Placebo ConTrolled Study Characterizing THe Effects of PCSK9 Inhibition On Arterial Wall Inflammation in Patients With Elevated Lp(a) (ANITSCHKOW)" @default.
- Q63571201 P17 Q16 @default.
- Q63571201 P17 Q30 @default.
- Q63571201 P17 Q55 @default.
- Q63571201 P1813 "ANITSCHKOW" @default.
- Q63571201 P2899 "+50" @default.
- Q63571201 P3098 "NCT02729025" @default.
- Q63571201 P31 Q30612 @default.
- Q63571201 P4135 "+80" @default.
- Q63571201 P4844 Q15623825 @default.
- Q63571201 P580 "2016-04-14T00:00:00Z" @default.
- Q63571201 P582 "2018-04-05T00:00:00Z" @default.
- Q63571201 P6099 Q42824827 @default.
- Q63571201 P8363 Q78089383 @default.
- Q63571201 P859 Q470517 @default.